`

Taisho Pharmaceutical Indonesia Tbk

Pharmaceutical Manufacturing

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
201 - 500

Frequently Asked Questions About Taisho Pharmaceutical Indonesia Tbk

What does Taisho pharmaceutical indonesia tbk do?+

Taisho Pharmaceutical Indonesia is the subsidiary of Taisho Pharmaceutical Co., Ltd., Japan - the number one over-the-counter medications company in Japan. In Indonesia, Taisho Pharmaceutical has been operating since the end of 2009 after acquiring Bristol-Myers Squibb. Our main brands are Counterpain, Tempra, Theragran-M, Kenacort, Myco-Z and Mycostatin OS (Oral Suspension)

What is Taisho pharmaceutical indonesia tbk's industry? +

Taisho pharmaceutical indonesia tbk operates in the Pharmaceutical manufacturing industry.

What is Taisho pharmaceutical indonesia tbk's revenue? +

Taisho pharmaceutical indonesia tbk's revenue is 11m - 100m

What is Taisho pharmaceutical indonesia tbk's company size? +

Taisho pharmaceutical indonesia tbk has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.